Open AccessUpdate on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association
Author(s) -
Caroline S. Fox,
Sherita Hill Golden,
Cheryl A.M. Anderson,
George A. Bray,
Lora E. Burke,
Ian H. de Boer,
Prakash Deedwania,
Robert H. Eckel,
Abby G. Ershow,
Judith Fradkin,
Silvio E. Inzucchi,
Mikhail Kosiborod,
Robert G. Nelson,
Mahesh J. Patel,
Michael Pig,
Laurie Quinn,
Philip R. Schauer,
Elizabeth Selvin,
Dorothea K. Vafiadis
Publication year - 2015
Publication title -
diabetes care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.636
H-Index - 363
eISSN - 1935-5548
pISSN - 0149-5992
DOI - 10.2337/dci15-0012
Subject(s) - medicine , diabetes mellitus , subclinical infection , disease , aspirin , intensive care medicine , type 2 diabetes mellitus , kidney disease , blood pressure , type 2 diabetes , family medicine , endocrinology
Cardiovascular disease risk factor control as primary prevention in patients with type 2 diabetes mellitus has changed substantially in the past few years. The purpose of this scientific statement is to review the current literature and key clinical trials pertaining to blood pressure and blood glucose control, cholesterol management, aspirin therapy, and lifestyle modification. We present a synthesis of the recent literature, new guidelines, and clinical targets, including screening for kidney and subclinical cardiovascular disease for the contemporary management of patients with type 2 diabetes mellitus.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom